Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20141209020258N117Phase 3Completed
Phase 3, randomised trial in postoperative pain comparing Intraperitoneal ropivacaine alone, Intraperitoneal ropivacaine + dexmedetomidine and Intraperitoneal ropivacaine + fentanyl (3 arms). Primary endpoint: postoperative pain intensity. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20141209020258N117.